These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Jones JS, Follis HW, Johnson JR. Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587 [Abstract] [Full Text] [Related]
4. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate. Zhigang Z, Wenlu S. Prostate; 2008 Feb 01; 68(2):190-9. PubMed ID: 18076024 [Abstract] [Full Text] [Related]
7. [Prostate cancer after prostatectomy for benign prostatic hyperplasia]. Hua L, Zhang J, Wu H, Sui Y, Zhang W, Qian L, Wang Z. Zhonghua Nan Ke Xue; 2004 Aug 01; 10(8):612-3. PubMed ID: 15362527 [Abstract] [Full Text] [Related]
8. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Helfand BT, Anderson CB, Fought A, Kim DY, Vyas A, McVary KT. Urology; 2009 Jul 01; 74(1):177-83. PubMed ID: 19428074 [Abstract] [Full Text] [Related]
14. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia. Bales GT, Flynn TJ, Kynaston HG, Golash A, Hart A, Kim HL, Gerber GS. Tech Urol; 2000 Sep 01; 6(3):201-4. PubMed ID: 10963487 [Abstract] [Full Text] [Related]